1. Cortical spreading depression augments kynurenate levels and reduces malonate toxicity in the rat cortex
- Author
-
Kiss, Csaba, Shepard, Paul D., Bari, Ferenc, and Schwarcz, Robert
- Subjects
- *
KYNURENINE , *BRAIN , *OCCIPITAL lobe , *LABORATORY rats - Abstract
Cortical spreading depression (CSD) is characterized by slowly propagating neuronal and astrocytic depolarization, resulting in transient, heightened resistance to subsequent neuronal injury. This study was designed to examine a possible role of the endogenous neuroprotective agent kynurenate (KYNA) in this phenomenon. Unilateral, consecutive CSDs, induced by topical application of 2 M KCl to the cortical surface of adult male rats, resulted in an ipsilateral increase (201–222% compared to controls) in KYNA levels, which was observed in the frontal, parietal and occipital cortex but not in other brain areas. This effect peaked on day 3 after CSD, and KYNA levels returned to normal on day 7. In separate rats, the lesion caused by an intracortical microinjection of the indirect excitotoxin malonate (500 nmol/0.5 μl) on days 1, 3 or 7 after CSD was reduced by 56–75% in the ipsilateral hemisphere. In normal rats, single or multiple injections of the kynurenine 3-hydroxylase inhibitor 4,5-dichlorobenzoylalanine (PNU 156561; 50 mg/kg, i.p.), which results in selective increases in brain KYNA levels, failed to protect cortical neurons against a focal malonate injection. Taken together, these findings indicate that the observed increase in brain KYNA is not responsible for CSD-induced tolerance to malonate-induced neuronal damage. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF